| 000 | 01442 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517001617.0 | ||
| 264 | 0 | _c20160523 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a2532-179X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBiswas, A | |
| 245 | 0 | 0 |
_aThe many faces of Pulmonary Langerhans Cell Histiocytosis. _h[electronic resource] |
| 260 |
_bSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG _cOct 2014 |
||
| 300 |
_a244-8 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aChoroid Diseases _xcomplications |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorescein Angiography |
| 650 | 0 | 4 |
_aHistiocytosis, Langerhans-Cell _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Diseases _xcomplications |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aSmoking Cessation |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVinblastine _xtherapeutic use |
| 700 | 1 | _aDonahoe, M | |
| 773 | 0 |
_tSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG _gvol. 31 _gno. 3 _gp. 244-8 |
|
| 999 |
_c24322348 _d24322348 |
||